Kymera Therapeutics Inc.

30.14
-1.21 (-3.86%)
At close: Mar 03, 2025, 3:59 PM
30.17
0.10%
After-hours: Mar 03, 2025, 04:00 PM EST

Kymera Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -13.49 -10.11 -8.87 -31.09 -24.48 -35.87 -68.99
PEG Ratio -0.74 0.95 -0.23 1.61 -0.14 -0.38 n/a
PS Ratio 64.14 18.91 28.75 41.83 31.61 504.79 n/a
PB Ratio 3.61 3.76 2.75 6.63 3.79 -19.91 -43.01
P/FCF Ratio -14.56 -10.82 -8.63 -23.34 13.61 85.25 -77.06
P/OCF Ratio -15.52 -14.45 -8.79 -23.63 12.21 82.72 -82.91
OCF/S Ratio -4.13 -1.31 -3.27 -1.77 2.59 6.10 n/a
Debt / Equity Ratio 0.11 0.21 0.04 0.04 0.06 -0.28 -0.02
Quick Ratio 7.53 4.73 9.04 5.71 4.21 2.69 8.92
Current Ratio 7.53 4.73 8.84 5.62 2.73 2.69 8.92
Asset Turnover 0.05 0.14 0.08 0.12 0.07 0.03 n/a
Interest Coverage -1.05K -844.54 -916.23 -574.46 -402.64 -917.5 -1.34K
Return on Equity (ROE) -0.27 -0.37 -0.31 -0.21 -0.15 0.55 0.62
Return on Assets (ROA) -0.23 -0.26 -0.25 -0.16 -0.09 -0.35 -0.49
Return on Capital (ROIC) -0.29 -0.34 -0.3 -0.2 -0.12 -0.51 -0.54
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% -140.59% 93.64% 96.71% -82.48% 71.88% n/a
Net Profit Margin -475.57% -186.99% -324.25% -134.55% -129.12% -1.41K% n/a
Pretax Profit Margin -475.57% -186.99% -330.6% -137.6% -133.96% -1.41K% n/a
Operating Profit Margin -555.82% -210.62% -344.37% -138.03% -136.05% -1.44K% n/a
FCF Margin -440.47% -174.71% -332.98% -179.24% 232.22% 592.13% n/a
EBITDA Margin -459.37% -182.21% -323.87% -134.07% -128.45% -1.38K% n/a